Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector




















Sort by: Date|Relevance

Golden Arrow Resources Buying Back 10% of Outstanding Shares, Exploration Temporarily Halted by ...

Golden Arrow Resources Buying Back 10% of Outstanding Shares, Exploration Temporarily Halted by Pandemic The Critical Investor takes a look at recent actions taken by this gold explorer. The coronavirus pandemic together with the Saudi Arabia-Ru...

Datadog Shares Trade 25% Higher on Strong Q1 Revenue Growth and Updated Full-Year Guidance

Shares of cloud platform company Datadog Inc. traded higher and established a new 52-week high price after it firm reported an 87% increase in Q1/20 year-over-year revenue. Cloud monitoring and analytics platform developer Datadog Inc. (DDOG:NASDAQ) yesterday an...

Dova Pharma Shares Rise 38% on Swedish Firm Takeover Offer

Shares of Dova Pharmaceuticals opened 38% higher today on news that the firm will be acquired by Swedish Orphan Biovitrum. The deal is reportedly valued at $915 million or $29/share. This morning Durham, N.C.-based Dova Pharmaceuticals Inc. (DOVA:NASDAQ) announced ...

Chembio Launches COVID-19 Test that Provides Quick Results from a Simple Finger Stick

Chembio Diagnostics shares traded higher and set a new 52-week high price after the company reported that it has launched a DPP® COVID-19 serological point-of-care test which can deliver IgM/IgG antibody results in 15 minutes using a simple finger stick. ...

United Natural Foods Share Rise 40% on Preliminary Q3/20 EPS Gain of 43%

Shares of United Natural Foods traded higher, setting a new 52-week high, after the company reported preliminary financial results for Q3/20, which demonstrated a 12% growth in y-o-y revenue and a 43% increase in earnings per share. Distributor and retailer of natu...

ArQule Shares Double on Proposed $2.7 Billion Tender Offer from Merck

ArQule Inc. shares traded more than 100% higher today after the company entered into definitive agreement to be acquired by a Merck subsidiary company for $20 per share. The deal is valued at $2.7 billion and is expected to close in the early part of Q1/20. This morni...

Aftermath Locks up a Boatload of Silver

When the precious metals bull begins to roar, silver roars along with it. In general, when the metals go down silver goes down more and faster than gold. When precious metals climb, silver climbs faster and goes higher. So if you believe that we are in a metals bull mar...

Pope Resources Shares Rise 35% on Rayonier $554 Million Takeover Bid

Pope Resources LP shares set a new 52-week intraday high price today after the timber resources firm announced that it agreed to be acquired by Rayonier for $554 million, or $126.91 per unit. The transaction is expected to close in mid-year 2020 subject to approval of Pope's u...

Exterran Shares Jump 20% Higher on Q4 Business Update

Shares of Exterran Corp. traded 20% higher after the company issued preliminary business operating results for the fourth quarter ended December 31, 2019. Houston, Tex.-based turnkey midstream infrastructure solutions firm Exterran Corp. (EXTN:NYSE) , which...

Alexion's Buyout of Portola Pharmaceuticals Gets Investors' Blood Flowing

Shares of Portola Pharmaceuticals traded 130% higher after the company reported that it has received an $18 per share buyout offer from Alexion Pharmaceuticals. Commercial-stage biotechnology company Portola Pharmaceuticals Inc. (PTLA:NASDAQ) , which focuse...
1 2 3 4 5 6 7 8 9 10 ...